A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James Smithy, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars-Sinai Medical Center
Los Angeles, California, United States
Recruiting - Stanford University (data Collection Only)
Stanford, California, United States
Recruiting - Hartford Healthcare Alliance (data Collection Only)
Hartford, Connecticut, United States
Recruiting - Memorial Sloan Kettering Basking Ridge (all Protocol Activities)
Basking Ridge, New Jersey, United States
Recruiting - Hackensack Meridian Health (data Collection Only)
Hackensack, New Jersey, United States
Recruiting - Memorial Sloan Kettering Monmouth (all Protocol Activities)
Middletown, New Jersey, United States
Recruiting - Memorial Sloan Kettering Bergen (limited Protocol Activities)
Montvale, New Jersey, United States
Recruiting - Memorial Sloan Kettering Suffolk - Commack (limited Protocol Activities)
Commack, New York, United States
Recruiting - Memorial Sloan Kettering Westchester (all Protocol Activities)
Harrison, New York, United States
Recruiting - Memorial Sloan Kettering Cancer Center (all Protocol Activities)
New York, New York, United States
Recruiting - Memorial Sloan Kettering Nassau (limited Protocol Activities)
Uniondale, New York, United States
Recruiting - Md Anderson Cancer Center (data Collection Only)
Houston, Texas, United States
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Sept 2024
- Primary completion
- 30 Sept 2027
- Completion
- 30 Sept 2027
- Last update posted
- 14 May 2026
- Registered enrollment
- 88
- Registry id
- NCT06594991
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.